🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Autobio Diagnostics Co Ltd (603658)

Shanghai
Currency in CNY
46.19
-0.40(-0.86%)
Closed
603658 Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
45.8747.10
52 wk Range
37.5666.36
Bid/Ask
46.15 / 46.17
Prev. Close
46.59
Open
46.75
Day's Range
45.87-47.1
52 wk Range
37.56-66.36
Volume
3,832,354
Average Volume (3m)
3,980,122
1-Year Change
-1.68%
Fair Value
Unlock
Fair Value Upside
Unlock
603658 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
58.14
Upside
+25.87%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry
Show more

Autobio Diagnostics Co Ltd Company Profile

Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products. It develops immunoassay, biochemistry, and microbiology products, as well as reagents; and instruments, as well as medical laboratory solutions. The company’s immunoassay products AutoLumo A1860 that provides user experience for small and medium size labs; an automated chemiluminescence immunoassay analyzer; AutoLumo A2000 Plus, an automatic chemiluminescence immunoassay analyzer; AutoLumo A1000, an automated chemiluminescence immunoassay analyzer; and LUmo microplate luminometers, PHOmo microplate readers, and iWO and iWO-960 microplate washers. Its microbiology products BC60, an automatic blood culture instrument; MALDI-TOF MS system for the identification of pathogenic bacteria; AutoMic-I60 for microbial identification and antibiotic susceptibility testing; BC120, an automated blood culture system; and AutoMimo 1200, an instrument for improving pipetting efficiency and optimize workflow in the lab. The company also offers blood culture bottles, AST cards, mycoplasma TIES, and AUTOF MS reagents; AutoMolec 1600, an integrated and automated molecular diagnostics analyzer; and AutoMolec 3000, an in vitro molecular detection instrument. In addition, it engages in biological research and development; and the provision of technical and support services. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is headquartered in Zhengzhou, China. Autobio Diagnostics Co., Ltd. operates as a subsidiary of Zhengzhou Autobio Co., Ltd.

Employees
5505
Market
China

Compare 603658 to Peers and Sector

Metrics to compare
603658
Peers
Sector
Relationship
P/E Ratio
20.8x22.8x−0.7x
PEG Ratio
2.19−0.560.00
Price/Book
3.1x2.7x2.6x
Price / LTM Sales
5.8x3.5x3.2x
Upside (Analyst Target)
23.4%24.3%43.9%
Fair Value Upside
Unlock15.3%6.5%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.2
Dividend Yield
2.28%
Industry Median 2.02%
Annualised payout
1.0521
Paid annually
5-Years Growth
+11.32%
Growth Streak

FAQ

What Is the Autobio Diagnostics (603658) Stock Price Today?

The Autobio Diagnostics stock price today is 46.19

What Stock Exchange Does Autobio Diagnostics Trade On?

Autobio Diagnostics is listed and trades on the Shanghai stock exchange.

What Is the Stock Symbol for Autobio Diagnostics?

The stock symbol for Autobio Diagnostics is "603658."

Does Autobio Diagnostics Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 2.28%.

What Is the Autobio Diagnostics Market Cap?

As of today, Autobio Diagnostics market cap is 26.43B.

What is Autobio Diagnostics Earnings Per Share?

The Autobio Diagnostics EPS is 2.20.

What Is the Next Autobio Diagnostics Earnings Date?

Autobio Diagnostics will release its next earnings report on 17 Apr 2025.

From a Technical Analysis Perspective, Is 603658 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.